4.5 Article

Optimizing Levothyroxine Dose Adjustment After Thyroidectomy With a Decision Tree

Journal

JOURNAL OF SURGICAL RESEARCH
Volume 244, Issue -, Pages 102-106

Publisher

ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/j.jss.2019.06.025

Keywords

-

Categories

Funding

  1. NIH [KL2TR000428, T35DK062709, UL1TR000427]

Ask authors/readers for more resources

Background: After thyroidectomy, patients require Levothyroxine (LT4). It may take years of dose adjustments to achieve euthyroidism. During this time, patients encounter undesirable symptoms associated with hypo- or hyper-thyroidism. Currently, providers adjust LT4 dose by clinical estimation, and no algorithm exists. The objective of this study was to build a decision tree that could estimate LT4 dose adjustments and reduce the time to euthyroidism. Methods: We performed a retrospective cohort analysis on 320 patients who underwent total or completion thyroidectomy at our institution. All patients required one or more LT4 dose adjustments from their initial postoperative dose before attaining euthyroidism. Using the Classification and Regression Tree algorithm, we built various decision trees from patient characteristics, estimating the dose adjustment to reach euthyroidism. Results: The most accurate decision tree used thyroid-stimulating hormone values at first dose adjustment (mean absolute error = 13.0 mu g). In comparison, the expert provider and naive system had a mean absolute error of 11.7 mu g and 17.2 mu g, respectively. In the evaluation dataset, the decision tree correctly predicted the dose adjustment within the smallest LT4 dose increment (12.5 mu g) 79 of 106 times (75%, confidence interval = 65%-82%). In comparison, expert provider estimation correctly predicted the dose adjustment 76 of 106 times (72%, confidence interval = 62%-80%). Conclusions: A decision tree predicts the correct LT4 dose adjustment with an accuracy exceeding that of a completely naive system and comparable to that of an expert provider. It can assist providers inexperienced with LT4 dose adjustment. (C) 2019 Elsevier Inc. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available